Clamor for GSK Shingles Shot Points to Bigger Profits Clamor for GSK Shingles Shot Points to Bigger Profits

GlaxoSmithKline is facing"unprecedented" demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger money-spinner than the company and analysts initially thought.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Business of Medicine News Source Type: news

Related Links:

(MedPage Today) -- Vaccine development may help with prevention of herpes zoster in this population
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
(Infectious Diseases Society of America) People newly diagnosed with cancer, particularly blood cancers, and those treated with chemotherapy have a greater risk of developing shingles, according to a new study in The Journal of Infectious Diseases. The findings may help guide efforts to prevent the often painful skin condition in cancer patients through the use of new vaccines.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Shortage of new shingles vaccine worsens as demand soars.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
This report evaluates the fifth year of the shingles vaccination programme in England from 2017 to 2018.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
A North Carolina school where a high concentration of families claim religious exemption from vaccines is facing the state’s worst chickenpox outbreak in more than 20 years. The chickenpox outbreak has affected 36 students at Asheville Waldorf School, health officials with Buncombe County said. The outbreak ranks as North Carolina’s largest since a chickenpox vaccine became available more than 20 years ago, the Asheville Citizen Times reports. The Asheville Waldorf School has one of the highest rates in the state of families who opt out of vaccines based on religious beliefs, according to data from North Caroli...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized chickenpox North Carolina onetime vaccines Source Type: news
-- Once you have had chickenpox, you are at risk for developing shingles, a painful skin rash and nerve disease that's caused by the same virus that causes chickenpox. Shingles can strike at any age, but usually affects adults after age 50, the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
According to the?Centers for Disease Control and Prevention,?almost 1 out of every 3 people in the U.S. will develop?shingles?in their lifetime. And the risk goes up with age. Vaccines can reduce the risk of shingles, while early treatment can shorten a shingles infection and lessen the chance of complications. In this Mayo Clinic Radio Radio [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
Vaccines against Hepatitis A and B, shingles, yellow fever and even rabies are just some of the injections Canadians are having a tough time finding.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
hon Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in peripheral ganglia. Decades later, the virus may reactivate either spontaneously or after a number of triggering factors to cause herpes zoster (shingles). Varicella and its complications are more severe in the immunosuppressed. The most frequent and important complication of VZV reactivation is postherpetic neuralgia, the cause of which is unknown and for which treatment is usually ineffective. Reactivation of VZV may also cause a wide variety of neurologic...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
AbstractThe herpes zoster (shingles) vaccine is recommended for all adults aged ≥ 60 years without contraindications to prevent shingles and post-herpetic neuralgia. There are no published studies on zoster vaccination rates, barriers, or workflows in adults who have experienced homelessness. Due to barriers specific to this vaccine, including difficulty determining insura nce coverage, high upfront costs, need for storage in a freezer, and under-prescription by physicians, uptake is lower compared to other recommended vaccines for older adults. To address these barriers, we developed a new approach of partn...
Source: Journal of Community Health - Category: International Medicine & Public Health Source Type: research
More News: Health | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines